Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Introduction
- Induced Pluripotent Stem Cells (iPSC) Generation
Chapter 3 Market Dynamics
- Global Market Dynamics
- Market Drivers
- Increasing Prevalence of Chronic Diseases
- Increasing Investment in Biotechnology Industry
- Increasing Demand for Personalized Medicines
- Increasing Investments for Drug Research and Development
- Demand for Effective Drug Discovery and Development Process
- Minimizing Animal Testing
- Market Restraints
- High Development Costs and Lack of Skilled Workforce
- Challenges Associated with iPSC-based Disease Modeling, Cell Therapy and Drug Discovery
- Market Opportunities
- Technological Advances
- Growth in iPSC Banking
Chapter 4 Emerging Technologies and Developments
- Advances in the iPSC Research
- Reprogramming Technologies
- Gene Editing Technologies
- 3D Organoids
- Regenerative Medicine
- Evolution and Current Application of Artificial Intelligence (AI) in iPSC Research
Chapter 5 Clinical Trial Analysis
Chapter 6 Patent Analysis
Chapter 7 Market Segmentation Analysis
- Segmentation Breakdown
- Overview
- Generation of Induced Pluripotent Stem Cells -- Market Analysis, by Reprogramming Method
- Market for Induced Pluripotent Stem Cells, by Generation Method
- Market for Induced Pluripotent Stem Cells, by Application
- Academic Research
- Pharmaco-toxicological Screening
- Drug Discovery and Development
- Disease Modeling
- Tissue Engineering
- Cell Therapy
- Global Market
- Regional Markets for iPSCs, by Application
- iPSC-derived Tissue Cell Market, by Type
- Cardiomyocytes
- Neurons
- Endothelial Cells
- Hepatocytes
- Other Cells
- iPSC-derived Tissue Cell Market, by Species
- Global Market
- iPSC-derived Tissue Cell Market, by Application
- Global Market
- Market for Induced Pluripotent Stem Cells, by Product Function
- Global Market
- Regional Markets for iPSCs, by Product Function
- Market for Induced Pluripotent Stem Cells, by End Use
- Induced Pluripotent Stem Cell Contract Service Types
- Major Players
- Global Market
- Geographic Breakdown
- Market for Induced Pluripotent Stem Cells, by Region
- The U.S.
- Europe
- Asia-Pacific
- Rest of the World
Chapter 8 Competitive Intelligence
- Competitive Landscape -- Overview
- Strategic Analysis
- Agreements
- Collaborations & Strategic Alliances
- Partnerships
- New Product Development and Launches
- Expansions and Acquisitions
- Fund Raising
- Approval and Clinical Trials
- Others
- Major Companies in Induced Pluripotent Stem Cells Market, by Type of Offerings
List of Tables
Summary Table: Global Market for Induced Pluripotent Stem Cells, by Reprogramming Method, Through 2028
Table 1: Projected Number of Adults 50 Years and Older with =1 Chronic Condition in the United States, 2020-2050
Table 2: The U.S. NIH Funding for Various Disease Conditions, 2019-2025
Table 3: Brief Information on iPSC Repositories
Table 4: Induced Pluripotent Stem Cells Pipeline, 2023
Table 5: List of Selected Patents Published on iPSC Technology, 2021
Table 6: List of Selected Patents Published on iPSC Technology, 2022
Table 7: List of Selected Patents Published on iPSC Technology, 2023
Table 8: List of Selected Patents Published on iPSC Technology, Till August 2024
Table 9: Summary of Different Reprogramming Methods
Table 10: Global Market for the Generation of Induced Pluripotent Stem Cells, by Reprogramming Method, Through 2028
Table 11: Global Market for Induced Pluripotent Stem Cells, by Method, Through 2028
Table 12: Selected Interventional Clinical Trials of iPSC-based Cell Therapy
Table 13: Global Market for Induced Pluripotent Stem Cells, by Application, Through 2028
Table 14: The U.S. Market for Induced Pluripotent Stem Cells, by Application, Through 2028
Table 15: European Market for Induced Pluripotent Stem Cells, by Application, Through 2028
Table 16: Asia-Pacific Market for Induced Pluripotent Stem Cells, by Application, Through 2028
Table 17: RoW Market for Induced Pluripotent Stem Cells, by Application, Through 2028
Table 18: Global Market for Induced Pluripotent Stem Cell-derived Tissue Cells, by Type, Through 2028
Table 19: Global Market for Induced Pluripotent Stem Cell-derived Tissue Cells, by Species, Through 2028
Table 20: Global Market for Induced Pluripotent Stem Cell-derived Tissue Cells, by Application, Through 2028
Table 21: Global Market for Induced Pluripotent Stem Cells, by Product Function, Through 2028
Table 22: The U.S. Market for Induced Pluripotent Stem Cells, by Product Function, Through 2028
Table 23: European Market for Induced Pluripotent Stem Cells, by Product Function, Through 2028
Table 24: Asia-Pacific Market for Induced Pluripotent Stem Cells, by Product Function, Through 2028
Table 25: RoW Market for Induced Pluripotent Stem Cells, by Product Function, Through 2028
Table 26: Global Market for Induced Pluripotent Stem Cells, by End Use, Through 2028
Table 27: Major Companies Providing iPSC Contract Services, by State/Country
Table 28: Global Market for Induced Pluripotent Stem Cell Contract Services, by Region, Through 2028
Table 29: Global Market for Induced Pluripotent Stem Cells, by Region, Through 2028
Table 30: The U.S. Market for Induced Pluripotent Stem Cells, by State, Through 2028
Table 31: European Market for Induced Pluripotent Stem Cells, by Country, Through 2028
Table 32: Asia-Pacific Market for Induced Pluripotent Stem Cells, by Country, Through 2028
Table 33: Agreements: Induced Pluripotent Stem Cells Market, 2019-2024
Table 34: Collaborations and Strategic Alliances: Induced Pluripotent Stem Cells Market, 2019-2024
Table 35: Partnerships: Induced Pluripotent Stem Cells Market, 2020-2023
Table 36: New Product Development and Launches: Induced Pluripotent Stem Cells Market, 2020-2023
Table 37: Expansions and Acquisitions: Induced Pluripotent Stem Cells Market, 2020-2023
Table 38: Fund Raising: Induced Pluripotent Stem Cells Market, 2020-2024
Table 39: Approvals and Clinical Trials: Induced Pluripotent Stem Cells Market, 2020-2024
Table 40: Other Competitive Strategies: Induced Pluripotent Stem Cells Market, 2020-2024
Table 41: Major Companies in the Induced Pluripotent Stem Cells Market
Table 42: Glossary of Terms Used in This Report
Table 43: Report Information Sources
Table 44: ATCC: Company Snapshot
Table 45: ATCC: Product Portfolio
Table 46: ATCC: News/Key Developments, 2023 and 2024
Table 47: Axol Bioscience Ltd.: Company Snapshot
Table 48: Axol Bioscience Ltd.: Product Portfolio
Table 49: Axol Bioscience Ltd.: News/Key Developments, 2021-2024
Table 50: Bio-Techne: Company Snapshot
Table 51: Bio-Techne: Financial Performance, FY 2022 and 2023
Table 52: Bio-Techne: Product Portfolio
Table 53: Bio-Techne: News/Key Developments, 2021-2023
Table 54: Fujifilm Cellular Dynamics Inc.: Company Snapshot
Table 55: Fujifilm Cellular Dynamics Inc.: Product Portfolio
Table 56: Fujifilm Cellular Dynamics Inc.: News/Key Developments, 2021-2023
Table 57: Lonza: Company Snapshot
Table 58: Lonza: Financial Performance, FY 2022 and 2023
Table 59: Lonza: Product Portfolio
Table 60: Lonza: News/Key Developments, 2020
Table 61: Merck KGaA: Company Snapshot
Table 62: Merck KGaA: Financial Performance, FY 2022 and 2023
Table 63: Merck KGaA.: Product Portfolio
Table 64: Merck KGaA: News/Key Developments, 2021-2024
Table 65: Ncardia: Company Snapshot
Table 66: Ncardia: Product Portfolio
Table 67: Ncardia: News/Key Developments, 2021-2024
Table 68: Qiagen: Company Snapshot
Table 69: Qiagen: Financial Performance, FY 2022 and 2023
Table 70: Qiagen: Product Portfolio
Table 71: REPROCELL Inc.: Company Snapshot
Table 72: REPROCELL Inc.: Product Portfolio
Table 73: REPROCELL Inc.: News/Key Developments, 2021-2024
Table 74: STEMCELL Technologies.: Company Snapshot
Table 75: STEMCELL Technologies: Product Portfolio
Table 76: STEMCELL Technologies: News/Key Developments, 2021-2022
Table 77: Takara Bio Inc.: Company Snapshot
Table 78: Takara Bio Inc.: Financial Performance, FY 2022 and 2023
Table 79: Taraka Bio Inc.: Product Portfolio
Table 80: Thermo Fisher Scientific Inc.: Company Snapshot
Table 81: Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 82: Thermo Fisher Scientific Inc.: Product Portfolio
Table 83: Thermo Fisher Scientific Inc.: News/Key Developments, 2023 and 2024
List of Figures
Summary Figure: Global Market for Induced Pluripotent Stem Cells, by Reprogramming Method, 2020-2028
Figure 1: Methodology for the Generation of Induced Pluripotent Stem Cells
Figure 2: Snapshot of the Market Dynamics for iPSCs
Figure 3: Venture Averages for Biopharma Therapeutics and Platform Companies, 2010-2024
Figure 4: Personalized Medicines Contribution in Total FDA Approvals, 2015-2023
Figure 5: Global Pharmaceutical R&D Spending, by Select Country/Region, 2010-2022
Figure 6: Phases of the Pharmaceutical Industry Research and Development Process
Figure 7: iPSC-derived Organoids Used for Drug Screening
Figure 8: Temporal Distribution of Studies Using ESCs, iPSCs, Somatic Cell Nuclear Transfer (SCNT) Cells and Parthenotic PSCs (pPSCs), Jan 1, 2011-Dec 13, 2022
Figure 9: Clinical-trial Analysis: Induced Pluripotent Stem Cells, as of August 2024
Figure 10: Number of Patents Documented Over Time on iPSC Technology, 2010-2024
Figure 11: Number of Granted Patents Documents on iPSC Technology, by Country, 2021-2024
Figure 12: PubMed Citations and Human iPSC Lines Registered in hPSCreg and EBiSC, 2007-2022
Figure 13: Published Applications of hiPSC Technology from Top 20 Pharma Companies, 2010-2020
Figure 14: Global Market for the Generation of Induced Pluripotent Stem Cells, by Reprogramming Method, 2020-2028
Figure 15: Global Market Shares of Induced Pluripotent Stem Cells, by Reprogramming Method, 2022
Figure 16: Global Market for Induced Pluripotent Stem Cells, by Method, 2020-2028
Figure 17: Global Market Shares of Induced Pluripotent Stem Cells, by Method, 2022
Figure 18: Utility of hiPSCs to Humanize Drug Discovery
Figure 19: Autologous and Allogeneic iPSC-Based Cell Therapy
Figure 20: Global Market for Induced Pluripotent Stem Cells, by Application, 2020-2028
Figure 21: Global Market Shares of Induced Pluripotent Stem Cells, by Application, 2022
Figure 22: The U.S. Market Shares of Induced Pluripotent Stem Cells, by Application, 2022
Figure 23: European Market Shares of Induced Pluripotent Stem Cells, by Application, 2022
Figure 24: Asia-Pacific Market Shares of Induced Pluripotent Stem Cells, by Application, 2022
Figure 25: RoW Market Shares of Induced Pluripotent Stem Cells, by Application, 2022
Figure 26: Global Market for Induced Pluripotent Stem Cell-derived Tissue Cells, by Type, 2020-2028
Figure 27: Global Market Shares of Induced Pluripotent Stem Cell-derived Tissue Cells, by Type, 2022
Figure 28: Global Market for Induced Pluripotent Stem Cell-derived Tissue Cells, by Species, 2020-2028
Figure 29: Global Market Shares of Induced Pluripotent Stem Cell-derived Tissue Cells, by Application, 2022
Figure 30: Global Market Shares of Induced Pluripotent Stem Cells, by Product Function, 2022
Figure 31: The U.S. Market Shares of Induced Pluripotent Stem Cells, by Product Function, 2022
Figure 32: European Market Shares of Induced Pluripotent Stem Cells, by Product Function, 2022
Figure 33: Asia-Pacific Market Shares of Induced Pluripotent Stem Cells, by Product Function, 2022
Figure 34: RoW Market Shares of Induced Pluripotent Stem Cells, by Product Function, 2022
Figure 35: Global Market Shares of Induced Pluripotent Stem Cells, by End Use, 2022
Figure 36: Global Market Shares of Induced Pluripotent Stem Cell Contract Services, by Region, 2022
Figure 37: Global Market Shares of Induced Pluripotent Stem Cells, by Region, 2022
Figure 38: NIH Spending on Induced Pluripotent Stem Cell Research in the U.S., 2015-2023
Figure 39: The U.S. Market Shares of Induced Pluripotent Stem Cells, by State, 2022
Figure 40: European Market Shares of Induced Pluripotent Stem Cells, by Country, 2028
Figure 41: Asia-Pacific Market Shares of Induced Pluripotent Stem Cells, by Country, 2022
Figure 42: Global Market Shares of Induced Pluripotent Stem Cells, by Key Strategies Adopted, 2019-2024
Figure 43: Bio-Techne: Revenue Share, by Business Unit, FY 2023
Figure 44: Bio-Techne: Revenue Share, by Country/Region, FY 2023
Figure 45: Lonza: Revenue Share, by Business Unit, FY 2023
Figure 46: Lonza: Revenue Share, by Country/Region, FY 2023
Figure 47: Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 48: Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 49: Qiagen: Revenue Share, by Business Unit, FY 2023
Figure 50: Qiagen: Revenue Share, by Country/Region, FY 2023
Figure 51: Takara Bio Inc.: Revenue Share, by Business Unit, FY 2023
Figure 52: Takara Bio Inc.: Revenue Share, by Country/Region, FY 2023
Figure 53: Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 54: Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
